These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8925081)

  • 1. Drug-protein binding sites. New trends in analytical and experimental methodology.
    Oravcová J; Böhs B; Lindner W
    J Chromatogr B Biomed Appl; 1996 Feb; 677(1):1-28. PubMed ID: 8925081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation and detection methods for covalent drug-protein adducts.
    Zhou S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 797(1-2):63-90. PubMed ID: 14630144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analytical methodology for drug-protein binding studies].
    Zhou D; Li L; Li F
    Se Pu; 2004 Mar; 22(2):116-20. PubMed ID: 15712865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecule-ligand binding studied by the Hummel and Dreyer method: current state of the methodology.
    Berger G; Girault G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 797(1-2):51-61. PubMed ID: 14630143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods of drug protein binding determinations.
    Sebille B
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():151s-161s. PubMed ID: 2093626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
    Pacifici GM; Viani A
    Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analytical strategy to measure drug-plasma protein interactions: from high-throughput to in-depth analysis.
    Vuignier K; Veuthey JL; Carrupt PA; Schappler J
    Drug Discov Today; 2013 Nov; 18(21-22):1030-4. PubMed ID: 23603634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding.
    Østergaard J; Heegaard NH
    Electrophoresis; 2003 Sep; 24(17):2903-13. PubMed ID: 12973793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
    Wabnitz PA; Loo JA
    Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data quality in drug discovery: the role of analytical performance in ligand binding assays.
    Wätzig H; Oltmann-Norden I; Steinicke F; Alhazmi HA; Nachbar M; El-Hady DA; Albishri HM; Baumann K; Exner T; Böckler FM; El Deeb S
    J Comput Aided Mol Des; 2015 Sep; 29(9):847-65. PubMed ID: 26070362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdialysis sampling for determination of plasma protein binding of drugs.
    Herrera AM; Scott DO; Lunte CE
    Pharm Res; 1990 Oct; 7(10):1077-81. PubMed ID: 2281040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation procedures used to reveal and follow drug-protein binding.
    Sebille B; Zini R; Madjar CV; Thuaud N; Tillement JP
    J Chromatogr; 1990 Oct; 531():51-77. PubMed ID: 2258425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced circular dichroism as a tool to investigate the binding of drugs to carrier proteins: Classic approaches and new trends.
    Tedesco D; Bertucci C
    J Pharm Biomed Anal; 2015 Sep; 113():34-42. PubMed ID: 25769668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
    Zhang F; Xue J; Shao J; Jia L
    Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.
    Kurz H; Trunk H; Weitz B
    Arzneimittelforschung; 1977 Jul; 27(7):1373-80. PubMed ID: 578456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity chromatography: a review of clinical applications.
    Hage DS
    Clin Chem; 1999 May; 45(5):593-615. PubMed ID: 10222345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
    Cheng Y; Ho E; Subramanyam B; Tseng JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.